170 related articles for article (PubMed ID: 1874190)
1. Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.
van der Pluijm G; Most W; van der Wee-Pals L; de Groot H; Papapoulos S; Löwik C
Endocrinology; 1991 Sep; 129(3):1596-604. PubMed ID: 1874190
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
4. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
5. Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption.
Corboz VA; Cecchini MG; Felix R; Fleisch H; van der Pluijm G; Löwik CW
Endocrinology; 1992 Jan; 130(1):437-42. PubMed ID: 1727717
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
7. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
8. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
9. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
12. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.
Pfeilschifter J; Chenu C; Bird A; Mundy GR; Roodman GD
J Bone Miner Res; 1989 Feb; 4(1):113-8. PubMed ID: 2785743
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
Thomson BM; Mundy GR; Chambers TJ
J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
17. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2.
de Vernejoul MC; Horowitz M; Demignon J; Neff L; Baron R
J Bone Miner Res; 1988 Feb; 3(1):69-80. PubMed ID: 3264994
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones.
Gronowicz GA; Derome ME
J Bone Miner Res; 1994 Feb; 9(2):193-201. PubMed ID: 8140932
[TBL] [Abstract][Full Text] [Related]
19. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro.
Feldman RS; Krieger NS; Tashjian AH
Endocrinology; 1980 Oct; 107(4):1137-43. PubMed ID: 7408763
[TBL] [Abstract][Full Text] [Related]
20. Effects of ionizing irradiation on formation and resorbing activity of osteoclasts in vitro.
Scheven BA; Burger EH; Kawilarang-de Haas EW; Wassenaar AM; Nijweide PJ
Lab Invest; 1985 Jul; 53(1):72-9. PubMed ID: 4010232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
